Rapidly progressive alopecia shows favorable prognosis

Rapidly progressive alopecia shows favorable prognosis
Patients with rapidly progressive alopecia areata tend to show favorable prognosis regardless of treatment selected, according to research published online Sept. 24 in the Journal of the American Academy of Dermatology.

(HealthDay)—Patients with rapidly progressive alopecia areata (RPAA) tend to show favorable prognosis regardless of treatment selected, according to research published online Sept. 24 in the Journal of the American Academy of Dermatology.

Over a three-year period, Masaki Uchiyama, M.D., from the Tokyo Medical University, and colleagues retrospectively analyzed 1,030 patients diagnosed with AA.

The researchers found that patients with regenerated vellus hairs showed a significantly higher improvement or cure rate regardless of AA severity. Lower rates of cure and higher rates of relapse were significantly associated with early onset and lengthy duration. Regardless of treatment utilized, RPAA patients tended to show a good prognosis.

"Our study suggested that there was no statistically significant influence of the initial treatment modalities on the prognosis of AA patients with , including both RPAA and chronic persistent AA," Uchiyama and colleagues conclude. "Recent studies have demonstrated that AA is associated with autoimmunity. However, RPAA patients tend to have a favorable prognosis, and the of curable RPAA is thought to be less associated with the autoimmune system than chronic forms of AA."

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Adolescents can benefit from 12-step involvement

Apr 16, 2012

Adolescents who misuse alcohol and other drugs to the point where they need treatment must contend with costly and limited options for youth-specific care, as well as high relapse rates following treatment. Mutual-help groups ...

Recommended for you

Cooling of dialysis fluids protects against brain damage

6 hours ago

While dialysis can cause blood pressure changes that damage the brain, cooling dialysis fluids can protect against such effects. The findings come from a study appearing in an upcoming issue of the Journal of the American So ...

Two Ebola vaccines to be tested in Switzerland

7 hours ago

Clinical trials of two experimental vaccines against the deadly Ebola virus are due to begin soon in Switzerland, the country's Tropical and Public Health Institute said on Thursday.

Legionnaire's disease kills four in Spain

11 hours ago

Four people have died from an outbreak of the lung infection Legionnaire's disease in northeastern Spain, regional health authorities said Thursday.

User comments